Glycoursodeoxycholic acid CAS NO.64480-66-6
Glycoursodeoxycholic acid CAS NO.64480-66-6

Glycoursodeoxycholic Acid (GUDCA) is a high-purity glycine-conjugated secondary bile acid, the major amidated metabolite of ursodeoxycholic acid (UDCA), isolated as a white to off-white crystalline powder for research use only. This endogenous metabolite is supplied as a reference standard for studying enterohepatic circulation, bile acid pool composition, and the metabolic signaling roles of conjugated bile acids in hepatocytes and intestinal models. It is primarily intended for pharmaceutical R&D scientists, metabolomics researchers, and biochemists investigating lipid metabolism, gut-liver axis signaling, and neuroprotective mechanisms mediated by bile acid receptors.

Ampicillin CAS NO.69-53-4
Ampicillin CAS NO.69-53-4

Ampicillin is a broad-spectrum semi-synthetic β-lactam antibiotic belonging to the aminopenicillin class, widely used in clinical medicine and life science research for its activity against a range of Gram-positive and Gram-negative bacteria. It is a cornerstone antibiotic for treating infections such as respiratory tract infections, meningitis, and endocarditis, and is also commonly employed in microbiology laboratories for selective culturing and antimicrobial susceptibility testing. Its ability to penetrate tissues and inhibit cell wall synthesis makes it a reliable choice for both therapeutic and experimental applications.

Sarafloxacin CAS NO.98105-99-8
Sarafloxacin CAS NO.98105-99-8

Sarafloxacin is a fluoroquinolone antibiotic featuring a broad-spectrum bactericidal action, highly effective against a wide range of veterinary and laboratory bacterial pathogens; it is specifically formulated for research and veterinary applications, offering rapid tissue penetration and prolonged efficacy in animal health studies and microbiological assays.

Bromodiphenhydramine hydrochloride CAS NO.1808-12-4
Bromodiphenhydramine hydrochloride CAS NO.1808-12-4

Bromodiphenhydramine hydrochloride is a high-purity, synthetic ethanolamine derivative supplied as a white to off-white crystalline powder, primarily utilized as a potent antihistamine standard for pharmaceutical R&D and clinical allergy research. This compound is specifically designed for scientists and laboratories investigating H1 receptor antagonism, anticholinergic effects, and the sedative properties of first-generation antihistamines in both in vitro cellular assays and preclinical animal models. It serves as a critical reference material for quality control in the production of allergy relief medications and is essential for researchers studying the pharmacokinetics and pharmacodynamics of brominated diphenhydramine analogs in the treatment of cutaneous allergies and motion sickness.

4-Acetyl-2-methylbenzoic acid CAS NO.55860-35-0
4-Acetyl-2-methylbenzoic acid CAS NO.55860-35-0

4-Acetyl-2-methylbenzoic acid is a high-purity aromatic carboxylic acid derivative, appearing as a white to yellowish crystalline powder, primarily utilized as a versatile organic synthesis building block and a critical pharmaceutical intermediate for advanced chemical manufacturing. Characterized by the presence of both a reactive carboxyl group and an acetyl ketone moiety on a methyl-substituted benzene ring, this compound offers excellent solubility in polar organic solvents such as DMSO, DMF, ethanol, and dichloromethane, while remaining stable under standard storage conditions. It is specifically designed for research scientists, API manufacturers, and agrochemical developers who require a reliable, high-quality precursor to construct complex molecular architectures, including active pharmaceutical ingredients (APIs) and high-performance functional materials.

Broxaldine CAS NO.3684-46-6
Broxaldine CAS NO.3684-46-6
Broxaldine is a synthetic quinoline derivative specifically designed for its remarkable ability to suppress gastric acid secretion, making it an invaluable chemical probe for gastroenterological research and a promising lead compound for developing anti-ulcer drugs that target potassium channels in parietal cells.
Tilmicosin CAS NO.108050-54-0
Tilmicosin CAS NO.108050-54-0

Tilmicosin is a macrolide antibiotic specifically developed for veterinary use, renowned for its exceptional efficacy against respiratory pathogens such as Mycoplasma and Gram-positive bacteria in livestock. It features a unique pharmacokinetic profile that allows for extensive tissue penetration and a long-lasting half-life, making it an ideal choice for the prevention and control of bovine and porcine respiratory diseases. This high-purity powder is designed for easy formulation into feed or water, providing reliable and sustained therapeutic levels to improve animal health and productivity in large-scale farming operations.

7-Acetyltaxol CAS NO.92950-39-5
7-Acetyltaxol CAS NO.92950-39-5

7-Acetyltaxol is a semi-synthetic derivative of paclitaxel, characterized as a white to off-white solid powder primarily utilized as a high-purity reference standard, impurity profiling marker (often identified as Paclitaxel EP Impurity L), and a vital tool for early-stage pharmacological research in oncology. This stable taxane analog features an acetyl group modification at the C-7 position, making it indispensable for researchers conducting structure-activity relationship (SAR) studies, analytical method validation, and the qualitative analysis of paclitaxel-based drug substances. It is specifically catered to pharmaceutical R&D scientists, quality control laboratories, and academic institutions requiring reliable chemical references to ensure drug safety, purity, and compliance with international pharmacopeial standards.

GS-441524 CAS NO.1191237-69-0
GS-441524 CAS NO.1191237-69-0

GS-441524 is a nucleoside analog and the active metabolite of Remdesivir (GS-5734), developed by Gilead Sciences as a broad-spectrum antiviral agent. It is widely recognized as a highly effective treatment for Feline Infectious Peritonitis (FIP), a once-fatal coronavirus disease in cats, and serves as a key pharmaceutical intermediate for antiviral research. The product is typically supplied as a high-purity white to off-white powder for research and development purposes in both medical and veterinary fields.

AST2818mesylate  CAS NO.2130958-55-1
AST2818mesylate CAS NO.2130958-55-1

AST2818 mesylate, also known as Alflutinib or Furmonertinib, is a highly selective third-generation EGFR tyrosine kinase inhibitor (TKI) developed for the targeted treatment of non-small cell lung cancer (NSCLC). It is specifically engineered to potently inhibit EGFR sensitizing mutations (such as exon 19 deletions and L858R) as well as the resistant T790M mutation, while exhibiting minimal off-target effects on wild-type EGFR, thereby offering a favorable safety profile for patients with advanced or metastatic disease.

Ceforanide CAS NO.60925-61-3
Ceforanide CAS NO.60925-61-3

Ceforanide (CAS 60925-61-3) is a high-purity, second-generation cephalosporin antibiotic provided as a reference standard. It is characterized as a parenteral, long-acting cephalosporin with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its chemical structure includes an aminothiazolyl moiety and a tetrazole ring, contributing to its enhanced stability against certain β-lactamases. Historically used clinically, it is now primarily utilized in pharmaceutical research as a model compound and a critical standard for quality control.

Cariprazine CAS NO.839712-12-8
Cariprazine CAS NO.839712-12-8

Cariprazine (CAS 839712-12-8) is a high-purity, atypical antipsychotic compound supplied as a reference standard. It is a piperazine derivative functioning as a dopamine D3 and D2 receptor partial agonist with preferential binding affinity for the D3 receptor. Approved by the FDA and EMA, it is clinically indicated for the treatment of schizophrenia, manic or mixed episodes associated with bipolar I disorder, and as an adjunctive therapy for major depressive disorder (MDD), representing a cornerstone in modern neuropsychiatric therapeutics.

High Purity Neurotensin Analogs and Exemestane Class Probes
Jul 06, 26
High Purity Neurotensin Analogs and Exemestane Class Probes
The pharmaceutical landscape is constantly evolving, with a significant focus on the development of highly specific ligands to decode complex biological systems. Within this context, the study of the exemestane class of research toolsspecifically high-purity peptide analogsplays a pivotal role in understanding receptor-mediated signaling. By utilizing precise molecular modifications, researchers can now probe the intricacies of the neurotensin system with unprecedented accuracy. Globally, the demand for specialized research probes has surged as medicinal chemistry shifts toward rational drug design. The ability to modulate binding affinity and selectivity between receptor subtypes is no longer a luxury but a necessity
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
Jul 03, 26
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
The landscape of biochemical analysis has been significantly transformed by the introduction of high-precision substrates, a field where the concept of exemestane 25 mg bodybuilding often appears in search queries despite the stark difference between clinical aromataze inhibitors and laboratory reagents. In the realm of pharmaceutical manufacturing and food science, the ability to quantify protease activity with absolute precision is paramount for maintaining product stability and quality. Understanding the mechanism of chromogenic substrates allows researchers to bridge the gap between raw biochemical data and commercial application.
Understanding the Therapeutic Role of exemestane drug class
Jul 01, 26
Understanding the Therapeutic Role of exemestane drug class
Understanding the Exemestane Drug Class and Its Therapeutic Role In the realm of endocrine therapy for breast cancer, identifying the correct exemestane drug class is critical for optimizing patient outcomes. Exemestane belongs to a specialized group of medications designed to inhibit the production of estrogen, which fuels the growth of hormone-receptor-positive breast cancers. Unlike earlier generations of hormone therapies, this class offers a more direct approach to enzymatic inhibition. By targeting the final step of estrogen synthesis, it provides a robust mechanism for managing postmenopausal oncology cases. Understanding the nuances of this pharmacological category allows researchers and clinicians to better navigate

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.